COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies

Type 2 diabetes mellitus, obesity, hypertension, and other associated metabolic complications have been demonstrated as a crucial contributor to the enhanced morbidity and mortality of patients with coronavirus disease 2019 (COVID-19). Data on the interplay between metabolic comorbidities and the ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Shuang, Yang, Yong, Zou, Danqi, Li, Jufei, Yan, Kaixuan, Xu, Ying, Jiang, Xue, Rong, Xianglu, Ye, Dewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101987/
https://www.ncbi.nlm.nih.gov/pubmed/34015585
http://dx.doi.org/10.1016/j.biopha.2021.111685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101987/
https://www.ncbi.nlm.nih.gov/pubmed/34015585
http://dx.doi.org/10.1016/j.biopha.2021.111685

Ejemplares similares